DK1053017T3 - Vacciner omfattende interleukin-12 og herpes simplex virusantigen - Google Patents
Vacciner omfattende interleukin-12 og herpes simplex virusantigenInfo
- Publication number
- DK1053017T3 DK1053017T3 DK99905946T DK99905946T DK1053017T3 DK 1053017 T3 DK1053017 T3 DK 1053017T3 DK 99905946 T DK99905946 T DK 99905946T DK 99905946 T DK99905946 T DK 99905946T DK 1053017 T3 DK1053017 T3 DK 1053017T3
- Authority
- DK
- Denmark
- Prior art keywords
- interleukin
- herpes simplex
- simplex virus
- vaccines
- virus antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7450398P | 1998-02-12 | 1998-02-12 | |
EP19990905946 EP1053017B1 (en) | 1998-02-12 | 1999-02-10 | Vaccines comprising interleukin-12 and herpes simplex viral antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1053017T3 true DK1053017T3 (da) | 2004-11-22 |
Family
ID=22119907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99905946T DK1053017T3 (da) | 1998-02-12 | 1999-02-10 | Vacciner omfattende interleukin-12 og herpes simplex virusantigen |
Country Status (15)
Country | Link |
---|---|
US (1) | US6488936B1 (da) |
EP (1) | EP1053017B1 (da) |
JP (1) | JP2002502884A (da) |
KR (1) | KR100622716B1 (da) |
CN (1) | CN1224422C (da) |
AT (1) | ATE275421T1 (da) |
AU (1) | AU764036B2 (da) |
BR (1) | BR9907883A (da) |
CA (1) | CA2320041A1 (da) |
DE (1) | DE69919984T2 (da) |
DK (1) | DK1053017T3 (da) |
ES (1) | ES2226338T3 (da) |
IL (1) | IL137811A (da) |
PT (1) | PT1053017E (da) |
WO (1) | WO1999040938A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01011499A (es) | 1999-05-13 | 2002-06-04 | American Cyanamid Co | Formulaciones de combinacion de adyuvantes. |
CN1222619C (zh) * | 1999-12-17 | 2005-10-12 | 惠氏控股公司 | 增强对单纯疱疹病毒疫苗应答的疫苗及其制药应用 |
US20070025958A1 (en) | 2000-10-27 | 2007-02-01 | Hadden John W | Vaccine immunotherapy |
JP2004521867A (ja) * | 2000-10-27 | 2004-07-22 | イミュノ−アールエックス, インコーポレイテッド | 免疫抑制された患者のためのワクチン免疫療法 |
AU2002225972B2 (en) * | 2000-11-10 | 2006-06-29 | Wyeth Holdings Corporation | Adjuvant combination formulations |
US6867000B2 (en) | 2000-12-07 | 2005-03-15 | Wyeth Holdings Corporation | Method of enhancing immune responses to herpes |
JP2004099584A (ja) * | 2002-05-02 | 2004-04-02 | Keio Gijuku | Hsvを用いた抗腫瘍剤 |
CN1301749C (zh) * | 2005-12-09 | 2007-02-28 | 复旦大学 | 抗单纯疱疹病毒-2感染的多表位dna疫苗及其制备方法 |
US7790203B2 (en) * | 2005-12-13 | 2010-09-07 | Lowder Tom R | Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
PT2468300T (pt) | 2006-09-26 | 2018-01-30 | Infectious Disease Res Inst | Composição para vacina contendo adjuvante sintético |
DK2429585T3 (da) | 2009-05-15 | 2018-07-30 | Irx Therapeutics Inc | Vaccine-immunterapi |
DK2437753T3 (da) | 2009-06-05 | 2016-12-19 | Infectious Disease Res Inst | Syntetiske glucopyranosyl-lipid-adjuvanser og vaccinesammensætninger, der indeholder dem |
WO2011056650A2 (en) * | 2009-10-27 | 2011-05-12 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
EP2510106B1 (en) | 2009-12-08 | 2018-02-14 | IRX Therapeutics, Inc. | Method of reversing immune suppression of langerhans cells |
CA2832307A1 (en) | 2011-04-08 | 2012-10-18 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
EP2850431B1 (en) | 2012-05-16 | 2018-04-18 | Immune Design Corp. | Vaccines for hsv-2 |
CA2909221A1 (en) | 2013-04-18 | 2014-10-23 | Immune Design Corp. | Gla monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022473A1 (en) * | 1993-04-01 | 1994-10-13 | University Of Washington | Use of interleukin 7 to improve vaccine potency |
US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
IL114576A0 (en) * | 1994-07-22 | 1995-11-27 | Merck & Co Inc | Polynucleotide herpes virus vaccine |
GB9422990D0 (en) * | 1994-11-15 | 1995-01-04 | Cortecs Ltd | Immunogenic compositions |
AU5507098A (en) * | 1995-12-19 | 1998-03-19 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Enhancement of dna immunization through the use of cytokines |
-
1999
- 1999-02-10 JP JP2000531189A patent/JP2002502884A/ja active Pending
- 1999-02-10 EP EP19990905946 patent/EP1053017B1/en not_active Expired - Lifetime
- 1999-02-10 KR KR1020007008769A patent/KR100622716B1/ko not_active IP Right Cessation
- 1999-02-10 PT PT99905946T patent/PT1053017E/pt unknown
- 1999-02-10 DK DK99905946T patent/DK1053017T3/da active
- 1999-02-10 US US09/247,635 patent/US6488936B1/en not_active Expired - Fee Related
- 1999-02-10 CA CA 2320041 patent/CA2320041A1/en not_active Abandoned
- 1999-02-10 BR BR9907883A patent/BR9907883A/pt not_active Application Discontinuation
- 1999-02-10 DE DE1999619984 patent/DE69919984T2/de not_active Expired - Fee Related
- 1999-02-10 CN CNB998043311A patent/CN1224422C/zh not_active Expired - Fee Related
- 1999-02-10 AU AU25981/99A patent/AU764036B2/en not_active Ceased
- 1999-02-10 WO PCT/US1999/002923 patent/WO1999040938A2/en active IP Right Grant
- 1999-02-10 IL IL13781199A patent/IL137811A/en not_active IP Right Cessation
- 1999-02-10 ES ES99905946T patent/ES2226338T3/es not_active Expired - Lifetime
- 1999-02-10 AT AT99905946T patent/ATE275421T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1999040938A2 (en) | 1999-08-19 |
CA2320041A1 (en) | 1999-08-19 |
US6488936B1 (en) | 2002-12-03 |
CN1224422C (zh) | 2005-10-26 |
DE69919984T2 (de) | 2005-11-17 |
WO1999040938A3 (en) | 2000-08-24 |
CN1299287A (zh) | 2001-06-13 |
ATE275421T1 (de) | 2004-09-15 |
AU2598199A (en) | 1999-08-30 |
IL137811A (en) | 2005-12-18 |
EP1053017A2 (en) | 2000-11-22 |
ES2226338T3 (es) | 2005-03-16 |
BR9907883A (pt) | 2000-11-14 |
DE69919984D1 (de) | 2004-10-14 |
KR20010040867A (ko) | 2001-05-15 |
AU764036B2 (en) | 2003-08-07 |
PT1053017E (pt) | 2004-12-31 |
EP1053017B1 (en) | 2004-09-08 |
KR100622716B1 (ko) | 2006-09-13 |
JP2002502884A (ja) | 2002-01-29 |
IL137811A0 (en) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1053017T3 (da) | Vacciner omfattende interleukin-12 og herpes simplex virusantigen | |
WO1999040936A3 (en) | Pneumococcal and meningococcal vaccines formulated with interleukin-12 | |
ATE315405T1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
FR20C1016I1 (da) | ||
ES2186809T3 (es) | Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso. | |
CA2185470A1 (en) | Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
AU7980794A (en) | Methods and compositions for microencapsulation of antigens for use as vaccines | |
ATE454163T1 (de) | Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren | |
HK1121382A1 (en) | Adjuvant compositions for enhancing immune responses to polynucleotide- based vaccines | |
AUPR011700A0 (en) | Composition comprising immunogenic virus sized particles (VSP) | |
CY2612B2 (en) | Compounds for immunotherapy and diagnosis of tuberculosis | |
MX9702336A (es) | Composiciones de vacuna. | |
WO2004032829A3 (en) | Immunostimulatory compositions and methods of stimulating an immune response | |
FI920132A0 (fi) | Stabila vaccinkompositioner innehaollande interleukiner. | |
CA2437201A1 (en) | Methods and compositions useful for stimulating an immune response | |
ATE377428T1 (de) | Rotavirus-impfstoff | |
WO2005012538A3 (en) | Accelerated vaccination | |
GB9818133D0 (en) | Vaccine | |
WO1999040937A3 (en) | Vaccines comprising interleukin-12 and respiratory syncytial viral antigens | |
AU8467201A (en) | Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses | |
WO2001035993A3 (en) | Compositions and methods for stimulating an immune response against infectious agents | |
SE9604322D0 (sv) | Bacterial antigens and vaccine compositions II | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
AU6761301A (en) | Adjuvant composition comprising fha protein or fragment of fha protein in free form |